Диссертация (1141136), страница 17
Текст из файла (страница 17)
//JACC. 2015. - Vol. 65.- P. 879 – 888.53.Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis andconduction delay in a patient with clinical signs of Brugada syndrome: acombined electrophysiological, genetic, histopathologic, and computationalstudy. // Circulation. - 2005. – Vol. 112. - P. 2769–2777.54.Coronel R, Wilms-Schopman FJ, Opthof T. Dispersion of repolarization andarrhythmogenesis.
// Heart Rhythm. – 2009/ - Vol. 6(4). - P. 537-543.55.Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underliessyndrome of right bundle branch block, ST segment elevation and suddendeath. // J Am Coll Cardiol. – 1996. Vol. 27. – P. 443–448.56.Darbar D, Yang T, Churchwell K, Wilde AA, Roden DM. Unmasking ofBrugada syndrome by lithium. // Circulation.
- 2005. – Vol. 112. – P. 1527–1531.57.Di Diego JM, Sun ZQ, Antzelevitch C. Ito and action potential notch aresmaller in left vs. right canine ventricular epicardium. // Am J Physiol. – 1996.- Vol. 271. – P. 548–561.58.Eckardt L, Kirchhof P, Loh P, et al.
Brugada syndrome and supraventriculartachyarrhythmias: a novel association? // Cardiovasc Electrophysiol. – 2001.– Vol. 12(6). – P. 680-685.12759.Eckardt L, Probst V, Smits JPP, et al. Long-term prognosis of individuals withright precordial ST-segment-elevation Brugada syndrome. // Circulation. –2005. Vol.
111. – P. 257-263.60.Fauchier L, Isorni MA, Clementy N, et al. Prognostic value of programmedventricular stimulation in Brugada syndrome according to clinicalpresentation: an updated meta-analysis of worldwide published data. // Int JCardiol. – 2013. – Vol. 168.
– P. 3027–3029.61.Fish JM, Antzelevitch C. Role of sodium and calcium channel block inunmasking the Brugada syndrome. // Heart Rhythm. – 2004. – Vol. 1(2). – P.210-217.62.Fowler S, Priori S. Clinical Spectrum of patients with a Brugada ECG. // CurrOpin Cardiol. – 2009. – Vol. 24. – P. 74–81.63.Fuller MS, Sándor G, Punske B., et al. Estimates of repolarization and itsdispersion from electrocardiographic measurements: direct epicardialassessment in the canine heart. // J Electrocardiol. – 2000.
- Vol. 33(2). - P.171-180.64.Gallagher MM, Forleo GB, Behr ER et al. Prevalence and significance ofBrugada-type ECG in 12,012 apparently healthy European subjects. // Int JCardiol. – 2008. - Vol. 130. - P. 44–48.65.Ghanem RN, Jia P, Ramanathan C, et al. Noninvasive ElectrocardiographicImaging (ECGI): Comparison to intraoperative mapping in patients. // Heartrhythm. – 2005. – Vol. 2(4). - P. 339-354.66.Goldenberg I, Mathew J, Moss AJ, et al. Corrected QT variability in serialelectrocardiograms in long QT syndrome: the importance of the maximumcorrected QT for risk stratification.
// J Am Coll Cardiol. – 2006. - Vol. 48. P. 1047–1052.67.Haïssaguerre M, Extramiana F, Hocini M, et al. Mapping and ablation ofventricular fibrillation associated with long-QT and Brugada byndrome. //Circulation. – 2003. – Vol. 108. – P. 925-92812868.Hedley PL, Jørgensen P, Schlamowitz S. The Genetic Basis of BrugadaSyndrome: A Mutation Update.
// Human Mutation. - 2009. - Vol. 30. – P.1256–1266.69.Hermida J-S, Lemoine J-L, Aoun FB et al. Prevalence of the Brugadasyndrome in an apparently healthy population. // Am J Cardiol. - 2000. – Vol.86. - P. 91-94.70.Hoogendijk MG, Potse M, Vinet A, et al. ST segment elevation by current-toload mismatch: an experimental and computational study. // Heart Rhythm. –2011. – Vol. 8(1). - P. 111-118.71.Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricularfibrillation in patients with Brugada syndrome detected by implantablecardioverter defibrillator therapy. // J Am Coll Cardiol. - 2000.
– Vol. 36. - P.1646 –1653.72.Kapplinger JD, Tester DJ, Alders M, et al. An international compendium ofmutation in the SCN5A-encoded cardiac sodium channel in patients referredfor Brugada syndrome genetic testing. // Heart Rhythm. – 2010. - Vol. 1. – P.33-46.73.Letsas KP, Gavrielatos G, Efremidis M., et al. Prevalence of Brugada sign ina Greek tertiary hospital population.
// Europace. – 2007. - Vol. 9. – P. 1077–1080.74.Litovsky SH, Antzelevitch C. Transient outward current prominent in canineventricular epicardium but not endocardium. // Circ Res. – 1988. - Vol. 62. –P. 116–126.75.Lukas A, Antzelevitch C. Phase 2 reentry as a mechanism of initiation ofcircus movement reentry in canine epicardium exposed to simulated ischemia:the antiarrhythmic effects of 4-aminopyridine. // Cardiovasc Res. – 1996. –Vol. 32.
– P. 593– 603.12976.Makita N, Behr E, Shimizu W, et al. The E1784K mutation in SCN5A isassociated with mixed clinical phenotype of type 3 long QT syndrome. // JClin Invest. - 2008. – Vol. 118. – P. 2219–2229.77.Matana A, Goldner V, Stanić K, et al. Unmasking effect of propafenone onthe concealed form of the Brugada phenomenon.
// Pacing ClinElectrophysiol. - 2000. – Vol. 23. – P. 416-41878.Maury P, Couderc P, Delay M, et al. Electrical storm in Brugada syndromesuccessfully treated using isoprenaline. // Europace. – 2004. – Vol. 6. – P.130-133.79.Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms ofBrugada syndrome: depolarizatiotion disorder, repolarization disorder, ormore? // Cardiovasc Res. – 2005. - Vol. 67. – P. 367–378.80.Millar CK, Kralios FA, Lux RL. Correlation between refractory periods andactivation-recovery intervals from electrograms: effects of rate and adrenergicinterventions. // Circulation. – 1985.
- Vol. 72(6) - P. 1372-1379.81.Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmicdrug modulation of ST segment elevation in patients with Brugada syndrome.// . – 1996. – Vol. 27(5) – P. 1061-1070.82.Mok NS, Chan NY, Chiu AC. Successful use of quinidine in treatment ofelectrical storm in Brugada syndrome. // Pacing Clin Electrophysiol. – 2004.Vol. 27(6 Pt 1). – P. 821-823.83.Myerburg RJ, Marchlinski FE, Scheinman MM. Controversy onelectrophysiology testing in patients with Brugada syndrome.
// HeartRhythm. – 2011. – Vol 8(12). – P. 1972-1974.84.Myerburg RJ. Implantable cardioverter-defibrillators after myocardialinfarction. // N Engl J Med. – 2008. – Vol. 359. - P. 2245–2253.85.Nademanee K, Veerakul G, Chandanamattha P, et al.
Prevention ofVentricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation130Over the Anterior Right Ventricular Outflow Tract Epicardium ClinicalPerspective. // Circulation. – 2011. – Vol. 123. – P. 1270-1279.86.Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations andsusceptibility to heart failure and atrial fibrillation. // JAMA. - 2005. – Vol.293. – P. 447–454.87.Osher HL, Wolff L. Electrocardiographic pattern simulating acute myocardialinjury. // Am J Med Sci. – 1953. – Vol. 226. – P. 541–545.88.Pastor A, Núñez A, Cantale C, Cosío FG. Asymptomatic Brugada syndromecaseunmaskedduringdimenhydrinateinfusion.//JCardiovascElectrophysiol.
– 2001. – Vol. 12. – P. 1192–1194.89.Pecini R, Cedergreen P, Theilade S, et al. The prevalence and relevance of theBrugada-type electrocardiogram in the Danish general population: data fromthe Copenhagen City Heart Study. // Europace. – 2010. – Vol. 12. – P. 982–986.90.Postema PG, van Dessel PF, de Bakker JM, et al.
Slow and discontinuousconduction conspire in Brugada syndrome: a right ventricular mapping andstimulation study. // Circ Arrhythm Electrophysiol. – 2008. – Vol. 1. – P. 379–386.91.Postema PG, van Dessel PF, de Bakker JM, et al. Slow and discontinuousconduction conspire in Brugada syndrome: a right ventricular mapping andstimulation study. // Circ Arrhythm Electrophysiol. – 2008.
– Vol. 1. – P. 379386.92.Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelinesfor the management of patients with ventricular arrhythmias and theprevention of sudden cardiac death. // European Heart Journal. – 2015. – Vol.36. - P. 2793–2867.93.Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugadasyndrome: results of the PRELUDE (Programmed ELectrical stimUlation131preDictive valuE) registry. // J Am Coll Cardiol. – 2012.
– Vol. 59. - P. 37–45.94.Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugadasyndrome: insights for risk stratification and management. // Circulation. 2002. – Vol. 105(11). – P. 1342–1347.95.Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneityof right bundle branch block and ST-segment elevation syndrome: aprospective evaluation of 52 families. // Circulation. – 2000. – Vol. 102.
– P.2509–2515.96.Priori SG, Napolitano C, Vicentini A. Inherited arrhythmia syndromes:applying the molecular biology and genetic to the clinical management. // JInterv Card Electrophysiol. - 2003. – Vol. 9. – P. 93–101.97.PrioriSG,WildeAA,HorieM,etal.Executivesummary:HRS/EHRA/APHRS expert consensus statement on the diagnosis andmanagement of patients with inherited primary arrhythmia syndromes. //Heart Rhythm.
– 2013. – Vol. 10(12). – P. 85-108.98.Probst V, Denjoy I, Meregalli PG., et al. Clinical aspects and prognosis ofBrugada syndrome in children. // Circulation. – 2007. – Vol. 115. – P. 20422048.99.Revishvili AS, Kalinin VV, Kalinin AV. Method of noninvasiveelectrophysiological study of the heart. U.S. Patient Number 8388547. - 2009.- November 23100. Revishvili AS, Wissner E, Lebedev DS, et al. Validation of the mappingaccuracyofanovelnon-invasiveepicardialandendocardialelectrophysiology system. // Europace. – 2015. - Vol. - 17(8). – P. 1282-1288.101.
Rossenbacker T, Carroll SJ, Liu H, et al. Novel pore mutation in SCN5Amanifests as a spectrum of phenotypes ranging from atrial flutter, conductiondisease, and Brugada syndrome to sudden cardiac death. // Heart Rhythm. 2004. – Vol. 1. – P. 610–615.132102. Rouleau F, Asfar P, Boulet S, et al. Transient ST segment elevation in rightprecordial leads induced by psychotropic drugs: relationship to the Brugadasyndrome. // J Cardiovasc Electrophysiol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
